Halozyme Therapeutics Common Stock Net 2010-2024 | HALO
- Halozyme Therapeutics common stock net for 2023 was $0B, a 5.93% decline from 2022.
- Halozyme Therapeutics common stock net for 2022 was $0B, a 2.17% decline from 2021.
- Halozyme Therapeutics common stock net for 2021 was $0B, a 2.22% increase from 2020.